Invesaro

Stocks NNBR Financial statements

Financial statements

NN INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NN INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue585620771490428478499489464422
Cost of revenue460588392344390421419395363
Gross profit1591829783.987.677.670.169.559.4
Selling, general and administrative64.174.172.868.958.151.549.647.449.546.2
Operating income34.831.8-195-17.6-117-9-21.1-21.8-27.5-18.9
Interest expense62.952.111.31318.912.71521.122.122.4
Other non-operating income2.872.08-2.02-0.960.215.375.06-10.74.564.57
Pre-tax income-30.9-60.2-208-32.1-152-22.4-31.1-53.7-45.4-39.7
Income tax-15.4-79.5-1.550.31-8.97-1.761.622.292.413.15
Net income6.66162-221-31.4-113-13.2-26.1-50.2-38.3-34
EBITDA85.584.2-15227.3-71.837.226.124.317.817
EPS, basic0.255.91-8.30-1.13-2.68-0.79-0.83-1.35-1.11-1.07
EPS, diluted0.255.85-8.30-1.13-2.68-0.79-0.83-1.35-1.11-1.07
Shares, basic (weighted)2727.431.74242.24444.746.748.749.4
Shares, diluted (weighted)2727.831.74242.24444.746.748.749.4
Dividend per share0.280.280.280.210.000.000.000.00

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents6.272241817.948.128.712.821.918.111.4
Receivables93.410813383.284.671.474.165.561.559.8
Inventory67.182.612167.162.57580.771.661.966
Other current assets7.0318.521.611.811.17.29.129.1910.510.5
Total current assets282477296303215196192183168164
Property, plant and equipment230259361256224209198186162159
Lease right-of-use assets045.550.346.446.743.439.335.2
Goodwill44445594.594.8000
Intangible assets25423813211710388.772.958.744.430.8
Other non-current assets8.116.317.618.575.744.195.2877.277.73
Total assets1,3581,4741,5011,542625579546511457441
Accounts payable44.75365.74137.436.745.945.538.949.4
Accrued liabilities17.221.124.615.621.317.711.715.519.914
Short-term debt12.817.331.319.14.893.073.323.915.045.79
Total current liabilities1401081451391037478.881.683.989.8
Long-term debt78679181175779151149149144154
Lease liabilities048.655.151.351.447.342.337.1
Other non-current liabilities14.312.529.440.517.217.39.9624.814.19.42
Total liabilities1,0499891,0821,096266301295308289294
Total debt82582986079384.9160154153149160
Paid-in capital285292509502493475468458456440
Retained earnings55.2211-58.5-105-206-219-245-295-334-368
Other comprehensive income-30.6-17.7-31.3-44.6-33.7-31.9-37.1-37.8-48.2-38.6
Shareholders' equity00-31.3-44.625422418612574.534
Minority interests0.03
Total equity30948541935325422418612574.534
Total liabilities and equity1,3581,4751,5011,542625579546511457441
Shares outstanding0.0327.642.142.342.74343.947.349.950.2

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income6.66162-263-46.7-101-13.2-26.1-50.2-38.3-34
Depreciation and amortization50.752.44344.945.746.247.246.145.335.9
Stock-based compensation3.945.52.422.824.233.224.382.823.143.2
Deferred income tax-15.5-23.2-9.562.35-15.5-4.14-1.79-1.16-0.92-0.88
Change in receivables-18.5-11.4-3.541.2710.813.7-4.929.09-2.844.13
Change in inventory4.38-8.94-16.21.435.11-13-6.67104.21-1.83
Change in payables7.634.122.69-7.9-8.610.348.621.14-3.8910.6
Cash from operations69.4-28.240.949.215.515.67.7229.311.15.67
Capital expenditures-43.8-43.7-64-54-23.8-18.2-18-20.5-18.3-12.9
Acquisitions0-38.4-39900
Cash from investing-41.2282-461-39.4719-36.1-17.5-17.6-1.01-11
Debt issued4432231254.266.2171466163.4
Debt repaid-55-314-291-108-776-93.7-48-65.4-96
Stock issued0021700
Dividends paid-7.58-7.7-8.83-8.8800
Cash from financing-24.5-45.82155.3-7152.56-5.19-2.88-13.2-2.45
Exchange rate effect-4.331.64-1.2-1.37-3.54-1.52-0.890.23-0.591.06
Net change in cash-0.68210-20613.716.4-19.5-15.89.1-3.78-6.75
Free cash flow25.5-72-23.1-4.8-8.22-2.64-10.28.85-7.24-7.25
Interest paid59.252.156.250.551.510.713.315.31817.9
Income taxes paid0.8972.3-32.66.432.247.624.743.483.914.93

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.67 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin15.0%Gross profit / revenue.
Operating margin-3.0%Operating income / revenue.
EBITDA margin5.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-7.7%Pre-tax income / revenue.
Net margin-6.2%Net income / revenue.
FCF margin1.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin4.7%Cash from operations / revenue.
Return on equity (ROE)-133.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-6.3%Net income / average total assets.
Return on invested capital (ROIC)-6.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue10.7%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.7%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.0%Capital expenditures / revenue.
D&A / revenue8.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-9.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-5.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-0.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-14.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-8.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-6.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-4.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-13.3%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y-48.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-9.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-18.3%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-54.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-43.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-33.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-3.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-6.9%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-6.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y1.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y3.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y3.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.79xCurrent assets / current liabilities.
Quick ratio0.91x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.17x(Cash + short-term investments) / current liabilities.
Debt / equity7.85xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets37.1%Total debt / total assets.
Liabilities / assets68.0%Total liabilities / total assets.
Net debt$150.0MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA6.49xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage-0.60xOperating income / interest expense.
Working capital$76.7MCurrent assets - current liabilities.
Goodwill and intangibles / assets5.3%(Goodwill + intangible assets) / total assets.
Tangible book value-$2.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.02xRevenue / average total assets.
Fixed asset turnover2.84xRevenue / average property, plant and equipment.
Inventory turnover5.59xCost of revenue / average inventory.
Days inventory65 days365 x average inventory / cost of revenue.
Receivables turnover6.32xRevenue / average receivables.
Days sales outstanding58 days365 x average receivables / revenue.
Days payables53 days365 x average accounts payable / cost of revenue.
Cash conversion cycle70 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow64.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.56Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$9.07Revenue / diluted weighted shares.
FCF per share$0.15Free cash flow / diluted weighted shares.
Operating cash flow per share$0.43Cash from operations / diluted weighted shares.
Book value per share$0.40Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.05Tangible book value / shares outstanding.
Cash per share$0.31(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$303.1MShare price x shares outstanding.
Enterprise value$453.1MMarket cap + total debt - cash - short-term investments.
P/S0.66xMarket cap / revenue.
P/B14.3xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF39.4xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF14.1xMarket cap / cash from operations, when positive.
EV/Sales0.99xEnterprise value / revenue.
EV/EBITDA19.6xEnterprise value / EBITDA, when both are positive.
EV/FCF58.9xEnterprise value / free cash flow, when both are positive.
FCF yield2.5%Free cash flow / market cap.
Earnings yield-9.3%Net income / market cap (the inverse of P/E).
What was NN INC's revenue in fiscal 2025?

NN INC reported revenue of $422.2M for fiscal 2025, 9.1% lower than the year before.

Was NN INC profitable in fiscal 2025?

No. It reported a net loss of $34.0M.

How much free cash flow did NN INC generate in fiscal 2025?

Cash from operations of $5.7M minus capital expenditures of $12.9M left free cash flow of -$7.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NN INC